Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sherry, Cao"'
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248889 (2021)
Idiopathic pulmonary fibrosis is a progressive and debilitating lung disease with large unmet medical need and few treatment options. We describe an analysis connecting single cell gene expression with bulk gene expression-based subsetting of patient
Externí odkaz:
https://doaj.org/article/d6e93ff9bbf14e6e8fece992efdac4b3
Autor:
Jacob F. Degner, Wade Davis, Wenliang Zhang, Sherry Cao, Marc C. Levesque, Corneliu A Bodea, Jozsef Karman, Yingchun Liu, Michael Macoritto, Emily A. King
Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) with a strong genetic component [1,2]. Genome-wide association studies (GWAS) have successfully identified over 240 genetic loci that are statistically associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b4f0254567d14fe4769869a7ecd2c72
https://doi.org/10.1101/2021.11.19.21266549
https://doi.org/10.1101/2021.11.19.21266549
Autor:
Sherry Cao, Sunny Jhamnani, Ido Haimi, Georgios Bouras, Regina Deible, Alexandra J. Lansky, Krishnankutty Sudhir, Vivian W. Mao, Vivian G. Ng
Publikováno v:
Catheterization and Cardiovascular Interventions. 89:984-991
Background Lesion length has been an important factor in predicting a worse outcome after percutaneous coronary interventions (PCI); however, the safety and efficacy of second-generation drug eluting stents in very long coronary lesions has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c5457ab11653754e5910844da59e35e
https://doi.org/10.1002/ccd.26711
https://doi.org/10.1002/ccd.26711
Autor:
Liang Jin, Yu Tian, Michael Macoritto, Yingtao Bi, Li Li, Sherry Cao, Jesus Paez-Cortez, Chenqi Hu
Publikováno v:
Inflammatory bowel diseases. 25(12)
Background Crohn's disease (CD) and ulcerative colitis (UC) are intestinal chronic inflammatory conditions characterized by altered epithelial barrier function and tissue damage. Despite significant efforts to understanding the biological mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe913cc554b75d0ab0809423f8f7c06e
https://pubmed.ncbi.nlm.nih.gov/31173627
https://pubmed.ncbi.nlm.nih.gov/31173627
Autor:
Krishnankutty Sudhir, Kleanthis Theodoropoulos, Alexandra J. Lansky, Robert S. Smith, Ali Rizvi, George Dangas, James B. Hermiller, Patrick W. Serruys, Dean J. Kereiakes, Donald E. Cutlip, William G. Newman, Gregg W. Stone, Sherry Cao
Publikováno v:
JACC-Cardiovascular interventions, 6(9), 914-922. Elsevier Inc.
Objectives This study sought to investigate whether the everolimus-eluting stent (EES) is superior to the paclitaxel-eluting stent (PES) with respect to long-term individual clinical outcomes. Background Individual studies have indicated a clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa6e7644e47cbed53061b19d02cd59ff
https://doi.org/10.1016/j.jcin.2013.05.005
https://doi.org/10.1016/j.jcin.2013.05.005
Autor:
Georgios, Bouras, Sunny, Jhamnani, Vivian G, Ng, Ido, Haimi, Vivian, Mao, Regina, Deible, Sherry, Cao, Krishnankutty, Sudhir, Alexandra J, Lansky
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 89(6)
Lesion length has been an important factor in predicting a worse outcome after percutaneous coronary interventions (PCI); however, the safety and efficacy of second-generation drug eluting stents in very long coronary lesions has not been validated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f570f69123cf94156140fbe7e54f8298
https://pubmed.ncbi.nlm.nih.gov/28488403
https://pubmed.ncbi.nlm.nih.gov/28488403
Autor:
Robert J. Applegate, Manejeh Yaqub, Krishnankutty Sudhir, James B. Hermiller, Kyoko Hattori, Sherry Cao, M. Hassan Pervaiz, Donald E. Cutlip, John C. Wang, Xiaolu Su, Gregg W. Stone, Dean J. Kereiakes, Poornima Sood, Liming Hou
Publikováno v:
Circulation: Cardiovascular Interventions. 5:150-156
Background— A consensus definition for periprocedural myocardial infarction (MI) in coronary stent trials has not been established. Differences between a historic definition, based on modified World Health Organization (WHO) criteria, and a propose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e238487ef6bd402cf679a6927d26a73a
https://doi.org/10.1161/circinterventions.111.965566
https://doi.org/10.1161/circinterventions.111.965566
Autor:
Poornima Sood, James B. Hermiller, Krishnankutty Sudhir, Gregg W. Stone, Manejeh Yaqub, Paul C. Gordon, Xiaolu Su, Robert J. Applegate, Sherry Cao
Publikováno v:
EuroIntervention. 7:1030-1042
To evaluate whether the improved outcomes with newer generation drug-eluting stents (DES) utilising thin-strut stents are consistent among different patient and angiographic subgroups.Clinical outcomes over three years were collected in the SPIRIT II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e85903fc558b3c7dfb59ddac920ac6
https://doi.org/10.4244/eijv7i9a165
https://doi.org/10.4244/eijv7i9a165
Autor:
Krishnakutty Sudhir M.D., R N Susan Bezenek, M.B.A. Poornima Sood M.D., Sherry Cao, James Hermiller, Manejeh Yaqub, R N Kyoko Hattori, Alexandra Lansky
Publikováno v:
Journal of Interventional Cardiology. 24:326-341
The XIENCE V® Everolimus-Eluting Coronary Stent System (EECSS) has been evaluated in multiple randomized controlled trials (RCTs) with several different comparators (SPIRIT FIRST, SPIRIT II, SPIRIT III, SPIRIT IV, COMPARE, ISAR-TEST 4, SORT-OUT IV,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b796aff87056940e3bfa37f3999d584e
https://doi.org/10.1111/j.1540-8183.2011.00628.x
https://doi.org/10.1111/j.1540-8183.2011.00628.x
Autor:
Charlene Manning, Fangxian Sun, Stephen L. Madden, Sherry Cao, Hongjing Qu, Richard C. Gregory, Robert J. Pomponio, Michele Sanicola-Nadel, Dmitri Wiederschain, Natalia Malkova, Gary Shapiro, Jean Cavallo, Christopher Winter, Tun Tun Lin, Joachim Theilhaber, Parminder Mankoo, Jack Pollard
Publikováno v:
Cancer Research. 78:5550-5550
TGFβ is a potent immunosuppressive cytokine, acting on multiple cell types of both the innate and adaptive immune systems. Emerging preclinical and clinical data implicate TGFβ in tumor immune evasion, poor prognosis and resistance to PD1/PDL1 dire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec1b26786e6e5ec52da7489620cc5bf5
https://doi.org/10.1158/1538-7445.am2018-5550
https://doi.org/10.1158/1538-7445.am2018-5550